European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. The second is an adjustment of unmet need categorisation required for RDP extension; unmet need definition now encompasses ‘meaningful’ impact patient outcomes (notably including quality of life).

Biopharma 82

Biopharma Pharmaceutical Medicine Manufacturing 82

MedCity News

OCTOBER 27, 2023

Technology is transforming how clinical trials are run. A panel during MedCity News’ INVEST Digital Health conference discussed the tech trends shaping the design and execution of drug studies.

Biopharma 125

Biopharma Patients Pharma 125

Pharmaceutical Technology

OCTOBER 4, 2022

Treatments to enhance the lives of debilitating neurological and neuropsychiatric disease patients are part of Biohaven’s portfolio. Combined with Pfizer’s global reach, this acquisition increases our potential to bring new treatment options to patients with migraine – a disease which affects over one billion people worldwide.”.

Biopharma 106

Biopharma Food and Drug Administration Medicine FDA 106

Fierce Pharma

SEPTEMBER 19, 2023

With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too. Especially with the proliferation of AI in other industries and chatGPT.

Biopharma 228

Biopharma Healthcare Healthcare Patients 228

Pharmaceutical Technology

MAY 26, 2023

HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development deal with NurrOn Pharmaceuticals to develop therapy for Parkinson’s disease (PD) and other neurodegenerative disorders. By activating Nurr1, ATH-399A slows disease progression in PD patients. They will help to progress ATH-399A towards a Phase I trial.

Biopharma 52

Biopharma Pharmaceutical Medicine Patients 52

Pharmaceutical Technology

JANUARY 24, 2023

BioCryst Pharmaceuticals is collaborating with Swixx BioPharma for Orladeyo (berotralstat) commercialisation in Central and Eastern Europe (CEE). Under the deal, Swixx BioPharma will handle the commercialisation activities of oral therapy in 15 CEE markets.

Biopharma 52

Biopharma Pharmaceutical Patients Marketing 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

We have focused on PD-1-IL-2 as a biology that has great potential for benefiting patients.”. The post Roche to acquire biopharma firm Good Therapeutics for $250m appeared first on Pharmaceutical Technology.

Biopharma 111

Biopharma Manufacturing Patients Pharma 111

Pharmaceutical Technology

SEPTEMBER 2, 2022

Forma focuses on researching, developing and marketing new therapies for patients with sickle cell disease (SCD), rare hematologic diseases and cancers. An oral, investigational, once-a-day, selective pyruvate kinase-R (PKR) activator, etavopivat is being developed to boost anaemia and the health of red blood cells in SCD patients.

Biopharma 105

Biopharma Leads Patients Pharmaceutical 105

Pharmaceutical Technology

MAY 10, 2023

Swedish Orphan Biovitrum (Sobi) has entered into a definitive agreement to buy biopharmaceutical company CTI BioPharma in an all-cash deal valued at $1.7bn. Vonjo has received the US Food and Drug Administration’s approval to treat myelofibrosis in adult patients with a platelet count below 50 x109/L.

Biopharma 59

Biopharma Food and Drug Administration Food Medicine 59

MedCity News

APRIL 23, 2024

ImmunityBio therapy Anktiva is now FDA approved for treating patients with non-muscle invasive bladder cancer. The post FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery appeared first on MedCity News. The novel immunotherapy works by sparking activity from three types of immune cells.

FDA 123

FDA Patients Biopharma Pharma 123

Pharmaceutical Technology

AUGUST 5, 2022

“We are excited to join in the Tavneos launch and help many more patients with this serious and sometimes life-threatening disease for which there remains significant unmet medical need.”. The post Amgen to acquire biopharma firm ChemoCentryx for $3.7bn appeared first on Pharmaceutical Technology.

Biopharma 96

Biopharma Food and Drug Administration Food Marketing 96

Pharmaceutical Technology

JUNE 2, 2023

Rentschler Biopharma has collaborated with Ikarovec for expediting the new gene therapies to treat ophthalmic disease. Under the deal, Rentschler Biopharma’s ATMP facility in Stevenage, UK, will undertake the bioprocess development of adeno-associated virus (AAV) material.

Biopharma 52

Biopharma Manufacturing Leads Pharmaceutical 52

pharmaphorum

JUNE 27, 2022

It is also approved for patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete surgical removal, and is in phase 3 testing as a combination therapy with rituximab and lenalidomide as a second-line therapy for FL. .

Biopharma 105

Biopharma Sales Prescription FDA 105

Pharmaceutical Technology

OCTOBER 12, 2022

Biotech start-up Toregem BioPharma has signed a memorandum of understanding (MoU) with WuXi Biologics to develop the monoclonal antibody, TRG035. We look forward to bringing this tooth regeneration drug to the global market, treating patients across the world.”. TRG035’s Phase I clinical study is scheduled to begin in early 2024.

Biopharma 52

Biopharma Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Commerce

DECEMBER 6, 2023

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

Biopharma 64

Biopharma Prescription Patients 64

Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. Biopharma companies are investing in the use of real world data (RWD) to accelerate innovation. The treatment of patients experiencing acute disease is quite dynamic.

Patients 59

Patients Biopharma Medical science Electronics 59

Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 The post invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m appeared first on Pharmaceutical Technology.

Biopharma 64

Biopharma Pharma Pharmacology Healthcare 64

MedCity News

MARCH 6, 2024

This case, about the claim that Merck failed to warn patients about the risk of typical femoral fracture, reaches past this suit to potentially change pharmaceutical companies’ relationship with the FDA.

Patients 120

Patients FDA Pharmaceutical Biopharma 120

pharmaphorum

AUGUST 5, 2022

Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions. The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace. About the Author.

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

pharmaphorum

APRIL 4, 2024

The company said that it was stopping access to the drug for new patients immediately, while those already taking it would be able to continue on it via a free drug programme, after consultation with their doctors – a move that has garnered praise from across the biopharma industry.

Marketing 95

Marketing Biopharma Doctors Consulting 95

MedCity News

APRIL 8, 2024

The expanded FDA approvals makes these cell therapies more accessible to more patients, broadening the market for both products. The post Cell Therapy Now Set to Reach More Patients With Expanded FDA Nod for 2 Multiple Myeloma Drugs appeared first on MedCity News.

FDA 122

FDA Patients Marketing Biopharma 122

PharmExec

APRIL 7, 2023

Biopharma companies can foster patient-centered innovation by focusing on unmet needs along each stage of the patient journey while collaborating with key stakeholders directly or indirectly responsible for disease management.

Patients 52

Patients Biopharma Medical Management 52

Pharmaceutical Technology

SEPTEMBER 20, 2022

The company intends to commence a randomised, controlled Phase II proof-of-concept clinical trial of VS-01, enrolling 60 ACLF patients in the fourth quarter of the year. The post Genfit agrees to acquire biopharma firm Versantis for $109m appeared first on Pharmaceutical Technology.

Biopharma 59

Biopharma Sales Management Pharmaceutical 59

MedCity News

DECEMBER 19, 2022

Historically, clinical trials have not prioritized the experiences of patients, who are required to frequently return on-site and engage with unfamiliar medical technology. They are often left in the dark regarding the data and health outcomes being collected through their participation.

Patients 104

Patients Medical Biopharma 104

MedCity News

FEBRUARY 20, 2024

The FDA clinical hold follows a patient death from liver failure that may be associated with zelnecirnon, an experimental Rapt Therapeutics drug. The biotech notes that no other patient has experienced liver problems and this safety signal has not been seen in any other tests of the molecule.

FDA 112

FDA Patients Safety Biopharma 112

Pharmaceutical Technology

NOVEMBER 2, 2022

However, over the same period, approvals for innovator small molecules treating rare diseases rose by 22%, giving hope to rare disease patients. The post China’s biopharma industry: the small molecule renaissance in rare diseases appeared first on Pharmaceutical Technology.

Biopharma 59

Biopharma Medical Pharmaceutical Patients 59

MedCity News

MAY 19, 2023

Companies presenting their technology at the conference seek to support a diverse patient population spanning conditions such as inflammatory bowel disease, food allergies, and cancer. Cell, gene therapy and immunotherapies also form some of their treatment approaches in development.

Biopharma 62

Biopharma Food Patients 62

Clarivate

JUNE 29, 2023

We’re mindful of some challenges that life science and healthcare organizations must work through before this technology is mature enough for use in critical business decisions that may impact patient health. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.

Patients 98

Patients Safety Healthcare Healthcare 98

MedCity News

SEPTEMBER 12, 2022

As the biopharma space gets more competitive and the days of blockbuster drugs seem further in the rearview, biopharma companies are investing in digital to find new and innovative ways to differentiate themselves.

Biopharma 98

Biopharma Medical Competition Patients 98

PharmaVoice

OCTOBER 16, 2023

Biopharma leaders pounding away at rare diseases so patients with few other options can have healthier lives.

Biopharma 108

Biopharma Patients 108

MedCity News

OCTOBER 16, 2023

With increased access to cutting-edge imaging, improved treatment options, greater personalization of treatment, reduced radiation exposure, and potential for future advances, patients can expect to receive more advanced medical care tailored to their specific needs through radiopharmaceuticals.

Patients 122

Patients Medical Biopharma 122

European Pharmaceutical Review

MAY 12, 2023

Swedish Orphan Biovitrum AB (Sobi ® ) has agreed to acquire CTI BioPharma for $1.7 There is a large unmet medical need within myelofibrosis, in particular for patients suffering from thrombocytopenia who are inadequately treated by existing medicines.

Food and Drug Administration 99

Food and Drug Administration Biopharma Medicine Food 99

Pharmaceutical Technology

AUGUST 9, 2022

“The deep market knowledge and scientific and clinical capabilities we have built over three decades in rare haematology will enable us to accelerate innovation for the sickle cell disease community and bring these treatments to patients as quickly as possible.”.

Biopharma 52

Biopharma Pharmaceutical Marketing Patients 52

MedCity News

JULY 20, 2022

By adding adherence and connectivity capabilities to home-based solutions, clinicians can maintain open lines of communication with patients, helping patients better care for themselves from the comfort of their homes.

Patients 143

Patients Biopharma 143

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

MedCity News

FEBRUARY 26, 2023

Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients more active participants in their own care.

Healthcare 120

Healthcare Healthcare Patients Biopharma 120

MedCity News

NOVEMBER 1, 2023

Investing in comprehensive patient concierge services keeps trial administrators on track by removing the burden of logistical support and improving the overall participant experience, making dropouts and trial delays much less likely.

Patients 117

Patients Biopharma 117